769
Views
45
CrossRef citations to date
0
Altmetric
Original Research

Preparation and optimization of lidocaine transferosomal gel containing permeation enhancers: a promising approach for enhancement of skin permeation

, &
Pages 1551-1562 | Published online: 26 Feb 2019

Figures & data

Table 1 Composition of the prepared transfersomes in molar ratio

Table 2 Composition of the prepared gel formulations with different chemical enhancers and respective concentrations used (% weight)

Table 3 Characteristic parameters of the loaded transferosomal vesicles

Figure 1 Transmission electron micrographs of the prepared transfersomes F4 when stained with uranyl acetate (10%) with scale 250 nm.

Figure 1 Transmission electron micrographs of the prepared transfersomes F4 when stained with uranyl acetate (10%) with scale 250 nm.

Figure 2 Release profiles of all the prepared transfersomes (each value was an average of three measurements ± SD).

Figure 2 Release profiles of all the prepared transfersomes (each value was an average of three measurements ± SD).

Figure 3 Rheogram representing the flow characteristics of transferosomal, free, and plain gel (dyne/cm2).

Figure 3 Rheogram representing the flow characteristics of transferosomal, free, and plain gel (dyne/cm2).

Table 4 The entrapment efficiency measurements (%) of the prepared transferosomal vesicles during storage at 4°C, 25°C, and 37°C over a period of 3 months

Table 5 The mean particle size measurements (nm) of the prepared transferosomal vesicles during storage at 4°C, 25°C, and 37°C over a period of 3 months

Table 6 The percent drug content (%) of the prepared gels during storage at 4°C, 25°C, and 37°C±2°C/75%±5% RH over a period of 3 months

Table 7 Comparative in vitro skin permeation and retention of lidocaine from various formulations

Table 8 Comparative maximum possible effect (%MPE; at 60 and 90 minutes) and AUC of various lidocaine-containing formulations

Figure 4 Effect of different permeation enhancers on the latency of tail flick after application 20 mg lidocaine equivalent in the tail flick test.

Abbreviations: PAMAM G3, polyamido amine dendrimer third generation; PG, propylene glycol.

Figure 4 Effect of different permeation enhancers on the latency of tail flick after application 20 mg lidocaine equivalent in the tail flick test.Abbreviations: PAMAM G3, polyamido amine dendrimer third generation; PG, propylene glycol.